How big is the compounded vs brand GLP-1 price difference in 2026?
As of November 20, 2026, a year of compounded tirzepatide at $129 a month (Eden or NexLife) costs $1,548, against about $5,637 for brand Zepbound vials on the label’s titration path, a gap of about $4,089. For semaglutide, Eden’s $99 a month is $1,188 a year against about $4,237 for Wegovy pens. Brand drugs are FDA-approved; compounded versions are not.
Released · Last reviewed · how we verify
Brand prices bought direct
| Medication | Dose | Self-pay price | Condition |
|---|---|---|---|
| Zepbound vial (LillyDirect) | 2.5 mg | $299 | per fill |
| Zepbound vial (LillyDirect) | 5 mg | $399 | per fill |
| Zepbound vial (LillyDirect) | 7.5–15 mg | $449 | each refill within 45 days; otherwise $499 (7.5 mg) or $699 (10–15 mg) |
| Wegovy pen (NovoCare) | 0.25–2.4 mg | $349 | new patients: $199 for each of the first two fills of 0.25 or 0.5 mg through December 31, 2026 |
| Wegovy HD pen (NovoCare) | 7.2 mg | $399 | per month |
| Wegovy pill (NovoCare) | 1.5 / 4 / 9 and 25 mg | $149 / $199 / $299 | per month |
| Foundayo (LillyDirect) | from 0.8 mg | from $149 | 2.5 and 5.5 mg temporarily reduced through December 31, 2026 |
Compounded tirzepatide prices, November 20, 2026
| Program | Month to month, all-in | Billing basis | Year at that price | Lowest printed rate | Dose pricing | Read |
|---|---|---|---|---|---|---|
| Collective | $85.58 | per month | $1,027 | $85.58 ($69 a month plus $199 a year) | same at every dose | 2026-11-20 |
| Mondae | $126 | per month | $1,512 | $114 (6-month plan, $684) | same at every dose | 2026-11-20 |
| NexLife | $129 | per month | $1,548 | $115 (12-month plan) | same at every dose | 2026-11-20 |
| Eden | $129 | per month | $1,548 | $129 (every month) | same at every dose | 2026-11-20 |
| Yucca Health | $139 | per month | $1,668 | $119 (12-month plan, $1,428 upfront) | same at every dose | 2026-11-20 |
| Fifty 410 | $199 | per 28-day cycle | $2,587 | $149.50 (8-week program at $299, not in all states) | not stated as flat | 2026-11-20 |
| Emerge Weight Loss | $269 | per 28-day cycle | $3,497 | $224 (2.5 mg, per 4 weeks) | not stated as flat | 2026-11-20 |
| OrderlyMeds | $299 | per month | $3,588 | $149 (2-month new-customer offer, $299) | same at every dose | 2026-11-20 |
| Noom Med | $299 | per 28-day cycle | $3,887 | $299 (per 4 weeks, billed $897 every 12 weeks) | not stated as flat | 2026-11-20 |
| Enhance.MD | $329 | per 28-day cycle | $4,277 | $280 (billed every 48 weeks) | not stated as flat | 2026-11-20 |
| Found | $339 | per 28-day cycle | $4,407 | $199 (12-month term, per 28-day cycle) | not stated as flat | 2026-11-20 |
| Remedy Meds | $399 | per 28-day cycle | $5,187 | $399 (4-week supply; $279 first month only) | same at every dose | 2026-11-20 |
Limitations of this answer
Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy. This page reports prices and terms; whether any GLP-1 suits you is a decision for you and a licensed clinician.
Frequently asked
How big is the compounded vs brand GLP-1 price difference in 2026?
As of November 20, 2026, a year of compounded tirzepatide at $129 a month (Eden or NexLife) costs $1,548, against about $5,637 for brand Zepbound vials on the label’s titration path, a gap of about $4,089. For semaglutide, Eden’s $99 a month is $1,188 a year against about $4,237 for Wegovy pens. Brand drugs are FDA-approved; compounded versions are not.
How current are the prices on TopGLP1Providers?
Every price on TopGLP1Providers carries the date it was read on the program’s own page; the whole dataset was re-read on November 20, 2026, from 2026-11-21 00:33 to 00:57 UTC, and NexLife’s plan pages were checked again for this site on November 21 (UTC). Programs whose pages refused automated reads that day, such as TrimRx, MEDVi, bmiMD, Embody, Ro and Hims & Hers, show no current price rather than an older one. When a program changes its price, the record, the pages that cite it and the changelog are updated together.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- NovoCare Pharmacy: Wegovy self-pay prices (read November 20, 2026)
- NexLife tirzepatide plans page (read November 20, 2026)